TrialAnnals of the rheumatic diseases2017

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.

John Gerry Coghlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.